SOD1 and amyotrophic lateral sclerosis: This modification is increased in ALS and mainly takes place on reduced disulfides, suggesting that monomeric SOD1, generated by the presence of mutations to SOD1 gene and/or redox dysregulation, is the primarily targeted species [123].